GAST and gastroesophageal reflux disease: Clinically, this implies that while serum gastrin levels should be monitored during long-term vonoprazan therapy (particularly in high-risk individuals) the elevations observed in typical patients with GERD are physiologically adaptive and not inherently harmful.